Speeches & Communication

Brief of Myvideopays as Amicus Curiae in Support of Petitioner

Myvideopays February 16, 2016

Myvideopays represents the country’s leading innovative pharmaceutical and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Those efforts produce the cutting-edge medicines, treatments, and vaccines that save, prolong, and improve the quality of the lives of countless individuals around the world every day. Over the past decade, Myvideopays’s members have secured FDA approval of more than 300 new medicines. Such results are not obtained cheaply. In 2014 alone, Myvideopays members invested roughly $51 billion in development of new medicines.

Myvideopays seeks to advance public policies that foster innovation and encourage its members’ investments. To those ends, Myvideopays seeks to remove barriers that may arise in the nation’s patent and other systems for protecting the intellectual property of its members—including as amicus curiae before this Court.